Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 FDA Issues Warning Letter for Off-Label Promotion of Orthopedic Implant - Medical Product Outsourcing

FDA Issues Warning Letter for Off-Label Promotion of Orthopedic Implant

The orthopedic implant company received CE Mark approval in 2008.

Orthopedic implants company Amedica Corp. promoted off-label use of its compact vertebral body replacement device without seeking marketing clearance by the U.S. Food and Drug Administration (FDA), according to a Jan. 27 warning letter from the agency.

The FDA considers the Valeo-C VBR misbranded because the company promoted uses that were not approved in its 510(k) application and made changes that could affect the safety and effectiveness of the device, the letter stated. The FDA investigated the company Aug. 7-20.

Amedica, which is based in Salt Lake City, Utah, received a CE mark for its Valeo family of ceramic spinal intervertebral spacers in 2008. The Valeo family of ceramic spinal intervertebral spacers is intended to aid in surgical correction and stabilization of the thoracolumbar spine.

See the entire warning letter at www.fda.gov/foi/warning_letters/s7113c.htm.

Add us as a preferred source on Google

Get the latest Medical Product Outsourcing news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters